Document is current
Any future updates will be listed below
-
Authors
Daly, Aidan C.
Cambuli, Francesco
Äijö, Tarmo
Lötstedt, Britta
Marjanovic, Nemanja Despot
Fernandez, Sara https://orcid.org/0000-0003-2281-4526
Kuksenko, Olena
Smith-Erb, Matthew
Domovic, Daniel https://orcid.org/0000-0003-4576-7988
Van Wittenberghe, Nicholas
Drokhlyansky, Eugene
Griffin, Gabriel K. https://orcid.org/0000-0002-4042-6757
Phatnani, Hemali
Bonneau, Richard
Regev, Aviv https://orcid.org/0000-0003-3293-3158
Vickovic, Sanja https://orcid.org/0000-0003-0985-9885
- License Information
-
More Information
Article History
Received: 16 April 2024
Accepted: 22 August 2025
First Online: 22 October 2025
Competing interests
: A.R. was a founder and equity holder of Celsius Therapeutics, is an equity holder in Immunitas Therapeutics and, until August 31, 2020, was a scientific advisory board member of Syros Pharmaceuticals, Neogene Therapeutics, Asimov and Thermo Fisher Scientific. Since August 1, 2020, A.R. has been an employee of Genentech and equity holder in Roche. Since August 5, 2021, R.B. has been an employee of Genentech. S.V. is an author on patents applied for by Spatial Transcriptomics AB (10X Genomics). S.V. and A.R. are coinventors on PCT/US2020/015481 relating to this work. The remaining authors declare no competing interests.
